title: Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
abstract: Meningiomas are usually benign tumors; however, they can recur after surgical resection and occasionally show histological progression to a higher malignancy grade. Five such rare cases of aggressively recurring meningiomas were present in our departmental cohort of 923 primary meningeal neoplasms operated over a 17-year period. Four other aggressively recurring meningeal tumors with a very similar clinical and histomorphological appearance (three undifferentiated meningeal sarcomas, one hemangiopericytoma) was also included in this study. We investigated whether disease progression can be traced by genetic alterations and whether a pattern of genetic alterations is specific for meningiomas. A total of 40 specimens from primary tumors and multiple recurrences of the nine patients were analyzed with 26 polymorphic allelic markers for deletions on 1p, 1q, 9q, 10q, 14q, and 22q. Loss of heterozygosity (LOH) at 22q was observed in all meningiomas cases at the earliest time point analyzed. Allelic loss at 1p was seen in the original tumor in two cases and upon meningioma recurrence in two others. Deletion on 10q occurred during tumor progression in two cases, and on 9q and 14q in one case. While allelic loss at 22q appears to be an early event in aggressive meningioma disease, there is a clear correlation of further deletions on chromosome arms 1p, 9q, 10q, and 14q with histopathological and clinical progression, as shown in these intraindividual trackings. None of these genetic findings were present in the non-meningiomatous meningeal tumors, indicating that meningothelial cells have their own lineage-specific genetic pathways towards clinical malignancy.
authors.affiliation: Department of Neurosurgery, University Hospital Eppendorf, Hamburg, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Lamszus
authors.forename: L
authors.initials: L
authors.lastname: Kluwe
authors.forename: J
authors.initials: J
authors.lastname: Matschke
authors.forename: H
authors.initials: H
authors.lastname: Meissner
authors.forename: R
authors.initials: R
authors.lastname: Laas
authors.forename: M
authors.initials: M
authors.lastname: Westphal
mesh_terms: D000328:Adult; D000368:Aged; D000483:Alleles; D002877:Chromosomes, Human; D002878:Chromosomes, Human, Pair 1; D002879:Chromosomes, Human, Pair 10; D002883:Chromosomes, Human, Pair 14; D002892:Chromosomes, Human, Pair 22; D002899:Chromosomes, Human, Pair 9; D018450:Disease Progression; D005260:Female; D006801:Humans; D019656:Loss of Heterozygosity; D008297:Male; D008577:Meningeal Neoplasms / Q000235:genetics* / Q000473:pathology; D008579:Meningioma / Q000235:genetics* / Q000473:pathology; D008875:Middle Aged; D012509:Sarcoma / Q000235:genetics* / Q000473:pathology